Treatment Planning & Management Flashcards

Which regulatory framework requires that inpatient treatment plans be reviewed and updated at specified intervals to reflect patient progress?

Answer: Conditions of Participation (CoP)

CMS Conditions of Participation require hospitals to review and update treatment plans at defined intervals to ensure care remains appropriate and goal-directed.

A healthcare analyst reviewing care coordination data finds that patients with chronic conditions who receive integrated treatment plans have 22% fewer readmissions. This outcome best supports which care model?

Answer: Patient-Centered Medical Home (PCMH)

The PCMH model emphasizes coordinated, patient-centered care with integrated treatment planning, which is associated with reduced readmissions for chronic disease patients.

When a treatment plan includes a medication with a narrow therapeutic index, what monitoring element is most critical to document?

Answer: Serum drug level and adverse effect surveillance schedule

Narrow therapeutic index drugs require documented serum level monitoring and adverse effect surveillance because small dose changes can cause toxicity or treatment failure.

In utilization management, a concurrent review of a treatment plan primarily aims to:

Answer: Determine medical necessity for continued inpatient stay

Concurrent review evaluates whether an ongoing inpatient stay and treatment plan meet medical necessity criteria to justify continued authorization.

Which metric best measures the effectiveness of a treatment planning process in reducing clinical variation?

Answer: Clinical pathway adherence rate

Clinical pathway adherence rate measures how consistently providers follow evidence-based treatment plans, directly reflecting reduction in unwarranted clinical variation.

A patient refuses a recommended component of their treatment plan. The most appropriate documentation step is to record:

Answer: Informed refusal, alternatives offered, and patient's stated reasoning

Documenting informed refusal — including alternatives discussed and patient reasoning — protects the patient's autonomy and the provider's legal standing.

Which data source is most useful to a healthcare analyst benchmarking treatment planning length-of-stay against national standards?

Answer: CMS Medicare Provider Analysis and Review (MedPAR) data

MedPAR data contains inpatient claim-level detail including diagnoses, procedures, and length of stay, making it the standard benchmarking source for LOS analysis.